PamelaLynKunzMD
Oncology • North Haven, CTGastrointestinal Cancer
Associate Professor, Medicine - Oncology, Yale Cancer Center
Dr. Kunz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Smilow Cancer Hospital - Yale North Haven
6 Devine Street
North Haven, CT 06473Phone+1 203-200-4422Fax+1 203-200-6950
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2008- Stanford Health Care-Sponsored Stanford UniversityChief Residency, Internal Medicine, 2004 - 2005
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2001 - 2004
Geisel School of Medicine at DartmouthClass of 2001
Certifications & Licensure
CA State Medical License 2002 - 2026
NY State Medical License 2024 - 2026
CT State Medical License 2020 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma Start of enrollment: 2009 Feb 01
- A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors Start of enrollment: 2009 Mar 01
- Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Modern Management of Gastric Neuroendocrine Neoplasms.John W Kunstman, Anil Nagar, Joanna Gibson, Pamela L Kunz
Current Treatment Options in Oncology. 2024-09-01 - 9 citations[Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gas...Simron Singh, Daniel Halperin, Sten Myrehaug, Ken Herrmann, Marianne Pavel
Lancet. 2024-06-29 - Correction to: PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Th...Dermot O'Toole, Pamela L Kunz, Susan M Webb, Grace Goldstein, Sheila Khawaja
Advances in Therapy. 2024-06-01
Press Mentions
2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023- Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
- GLOW Trial: Zolbetuximab plus CAPOX Extends Survival in Gastric Cancer SubtypeMarch 23rd, 2023
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
